Cargando…
Can the AHCL System Be Used in T1D Patients with Borderline TDDI? A Case Report
(1) Background: Intensive insulin therapy using continuous subcutaneous insulin infusion (CSII) with continuous real-time glucose monitoring (rt CGM) is the best option for patients with T1D. The recent introduction of a technology called Advanced Hybrid Closed Loop (AHCL) represents a new era in th...
Autores principales: | Tekielak, Anna, Seget, Sebastian, Rusak, Ewa, Jarosz-Chobot, Przemysława |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587306/ https://www.ncbi.nlm.nih.gov/pubmed/34770502 http://dx.doi.org/10.3390/s21217195 |
Ejemplares similares
-
Commercial hybrid closed-loop systems available for a patient with type 1 diabetes in 2022
por: Seget, Sebastian, et al.
Publicado: (2023) -
Prospective Open-Label, Single-Arm, Single-Center Follow-Up Study of the Application of the Advanced Hybrid Closed Loop System in Well-Controlled Children and Adolescents with Type 1 Diabetes
por: Seget, Sebastian, et al.
Publicado: (2022) -
The Use of a Hybrid Closed-Loop System for Glycemic Control in Two Pediatric Patients with Type 1 Diabetes Undergoing Minor Surgery
por: Seget, Sebastian, et al.
Publicado: (2023) -
The Quality of Life and Satisfaction with Continuous Glucose Monitoring Therapy in Children under 7 Years of Age with T1D Using the rtCGM System Integrated with Insulin Pump—A Caregivers Point of View
por: Rusak, Ewa, et al.
Publicado: (2021) -
Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study
por: Seget, Sebastian, et al.
Publicado: (2022)